ORN Q1 2026 Earnings Earnings Beat Expectations with Surprise Profit Despite Unreported Revenue Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats AWX Q4 2025 Earnings Narrowing Losses Amid Quiet Quarter PARR Q1 2026 Earnings Earnings Miss Weighs on Results but Stock Edges Higher IRIX Q1 2026 Earnings NarrowerThanExpected Loss Marks Positive Surprise COCP Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline MWA Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage RPM Q1 2026 Earnings Stellar EPS Surprise of 5993 Drives Stock Higher GMHS Q1 2026 Earnings EPS of 004 Reported Amid Limited Disclosure Stock Falls 501 BOTJ Q1 2025 Earnings Modest Profit Amidst a Quiet Quarter PLCE Q1 2026 Earnings EPS Misses by Wide Margin as Headwinds Persist MNRO Q1 2026 Earnings EPS Surprise of 1536 Drives Stock Higher